Amgen will present at Citi's 2025 Virtual Oncology Leadership Summit at 3:00 p.m. ET on Wednesday, Feb. 19, 2025. Jean-Charles Soria, senior vice president of oncology within global development at ...
Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
DIA, a global multidisciplinary life sciences membership association, will bring together thousands of stakeholders from all ...
The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to 2033" report has been added to ...
Analysis by Mount Sinai researcher from First-of-its kind global trial could lead to future therapies to prevent deadly ...
HyClone Laboratories, LLC (“HyClone”), a cell culture media supplier, filed a Motion to Quash a subpoena issued by Amgen, ...
It’s Black History Month! Gayle Anderson reports from the California Science Center about the development of the new Samuel ...
A dairy worker in Nevada is the state’s first human case of bird flu after the employee was exposed to infected dairy cattle.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback